Publications
-
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
Pollyea DA,
Kohrt HE, Zhang B, Zehnder J, Schenkein D, Fantin V, Straley K, Vasanthakumar A, Abdel-Wahab O, Levine R, Godley LA, Medeiros BC.
Leuk Lymphoma.
2013;
54
(2):
408-10
-
A distinct evolution of the T cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease.
Meyer EH,
Hsu AR, Liliental J, Löhr A, Florek M, Zehnder JL, Strober S, Lavori P, Miklos DB, Johnson DS, Negrin RS.
Blood.
2013
-
Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.
Sweeney RT,
Zhang B, Zhu SX, Varma S, Smith KS, Montgomery SB, van de Rijn M, Zehnder J, West RB.
Am J Surg Pathol.
2013;
37
(6):
796-803
-
Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.
Price EA,
Jin J, Nguyen HM, Krishnan G, Bowen R, Zehnder JL.
Ann Pharmacother.
2013;
47
(2):
151-8
-
Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma.
Ohgami RS,
Arber DA, Zehnder JL, Natkunam Y, Warnke RA.
Adv Anat Pathol.
2013;
20
(3):
137-40
-
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.
Logan AC,
Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, Krampf MR, Jones CD, Waqar AN, Faham M, Zehnder JL, Miklos DB.
Leukemia.
2013
-
STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
Ohgami RS,
Ma L, Merker JD, Martinez B, Zehnder JL, Arber DA.
Leukemia.
2013
-
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.
Pollyea DA,
Zehnder J, Coutre S, Gotlib JR, Gallegos L, Abdel-Wahab O, Greenberg P, Zhang B, Liedtke M, Berube C, Levine R, Mitchell BS, Medeiros BC.
Haematologica.
2013;
98
(4):
591-6
-
Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
Batra R,
Medeiros BC, Zehnder JL, Warnke RA, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2012;
20
(3):
325-30
-
Controversies in heparin monitoring.
Zehnder J,
Price E, Jin J.
Am J Hematol.
2012:
87 Suppl 1
S137-40
-
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.
Arai S,
Sahaf B, Narasimhan B, Chen GL, Jones CD, Lowsky R, Shizuru JA, Johnston LJ, Laport GG, Weng WK, Benjamin JE, Schaenman J, Brown J, Ramirez J, Zehnder JL, Negrin RS, Miklos DB.
Blood.
2012;
119
(25):
6145-54
-
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.
Pollyea DA,
Kohrt HE, Gallegos L, Figueroa ME, Abdel-Wahab O, Zhang B, Bhattacharya S, Zehnder J, Liedtke M, Gotlib JR, Coutre S, Berube C, Melnick A, Levine R, Mitchell BS, Medeiros BC.
Leukemia.
2012;
26
(5):
893-901
-
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.
Medeiros BC,
Kohrt HE, Gotlib J, Coutre SE, Zhang B, Arber DA, Zehnder JL.
Am J Hematol.
2012;
87
(1):
45-50
-
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
Ohgami RS,
Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA.
Am J Surg Pathol.
2012;
36
(11):
1619-28
-
A novel splice donor mutation in the thrombopoietin gene leads to exon 2 skipping in a Filipino family with hereditary thrombocythemia.
Zhang B,
Ng D, Jones C, Oh ST, Nolan GP, Salehi S, Wong W, Zehnder JL, Gotlib J.
Blood.
2011;
118
(26):
6988-90
-
Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL.
Tseng D,
Jones CD, Anderson M, Warnke R, Zehnder JL, Miklos DB.
Bone Marrow Transplant.
2011;
46
(12):
1576-8
-
Evaluation of a gene expression microarray-based assay to determine tissue type of origin on a diverse set of 49 malignancies.
Beck AH,
Rodriguez-Paris J, Zehnder J, Schrijver I.
Am J Surg Pathol.
2011;
35
(7):
1030-7
-
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment.
Logan AC,
Gao H, Wang C, Sahaf B, Jones CD, Marshall EL, Buño I, Armstrong R, Fire AZ, Weinberg KI, Mindrinos M, Zehnder JL, Boyd SD, Xiao W, Davis RW, Miklos DB.
Proc Natl Acad Sci U S A.
2011;
108
(52):
21194-9
-
Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.
Oliver SL,
Sommer MH, Reichelt M, Rajamani J, Vlaycheva-Beisheim L, Stamatis S, Cheng J, Jones C, Zehnder J, Arvin AM.
J Virol.
2011;
85
(9):
4095-110
-
Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies.
Ohgami RS,
Ohgami JK, Pereira IT, Gitana G, Zehnder JL, Arber DA.
Leukemia.
2011;
25
(9):
1439-43
-
The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP.
Zhang B,
Lo C, Shen L, Sood R, Jones C, Cusmano-Ozog K, Park-Snyder S, Wong W, Jeng M, Cowan T, Engleman EG, Zehnder JL.
Blood.
2011;
117
(17):
4569-79
-
Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
Zerboni L,
Berarducci B, Rajamani J, Jones CD, Zehnder JL, Arvin A.
J Virol.
2011;
85
(1):
98-111
-
Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.
Vleck SE,
Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM.
J Virol.
2010;
84
(1):
141-52
-
Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses.
Zhang B,
Beck AH, Taube JM, Kohler S, Seo K, Zwerner J, Viakhereva N, Sundram U, Kim YH, Schrijver I, Arber DA, Zehnder JL.
J Mol Diagn.
2010;
12
(3):
320-7
-
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.
Jones CD,
Arai S, Lowsky R, Tyan DB, Zehnder JL, Miklos DB.
Br J Haematol.
2010;
150
(5):
637-9
-
Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population.
Chan OT,
Westover KD, Dietz L, Zehnder JL, Schrijver I.
Am J Clin Pathol.
2010;
133
(5):
700-7
-
Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory.
Merker JD,
Jones CD, Oh ST, Schrijver I, Gotlib J, Zehnder JL.
J Mol Diagn.
2010;
12
(1):
58-64
-
Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry.
Hayward CP,
Moffat KA, Raby A, Israels S, Plumhoff E, Flynn G, Zehnder JL.
Am J Clin Pathol.
2010;
134
(6):
955-63
-
Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
Lo CY,
Jones C, Glader B, Zehnder JL.
Pediatr Blood Cancer.
2010;
55
(6):
1195-7
-
Future research in ITP: an ICIS consensus.
Zehnder JL,
Semple JW, Imbach P, Neufeld EJ, Buchanan GR, Cines DB.
Ann Hematol.
2010
-
Heparin-induced thrombocytopenia: current status and diagnostic challenges.
Otis SA,
Zehnder JL.
Am J Hematol.
2010;
85
(9):
700-6
-
Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation.
Matsukuma KE,
Mullins FM, Dietz L, Zehnder JL, Ford JM, Chun NM, Schrijver I.
Hum Pathol.
2010;
41
(8):
1200-3
-
Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements.
Boyd SD,
Gaëta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Collins AM.
J Immunol.
2010;
184
(12):
6986-92
-
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.
Oh ST,
Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KD, Merker JD, Zehnder JL, Nolan GP, Gotlib J.
Blood.
2010;
116
(6):
988-92
-
Presentation of extranodal natural killer T-cell lymphoma, nasal type, with poorly circumscribed erythematous patches.
Pincus LB,
Zehnder JL, Neuhaus IM, Andreadis C, McCalmont TH.
J Clin Oncol.
2010;
28
(6):
e94-5
-
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.
Weinberg OK,
Seetharam M, Ren L, Seo K, Ma L, Merker JD, Gotlib J, Zehnder JL, Arber DA.
Blood.
2009;
113
(9):
1906-8
-
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
Abrahamsson AE,
Geron I, Gotlib J, Dao KH, Barroga CF, Newton IG, Giles FJ, Durocher J, Creusot RS, Karimi M, Jones C, Zehnder JL, Keating A, Negrin RS, Weissman IL, Jamieson CH.
Proc Natl Acad Sci U S A.
2009;
106
(10):
3925-9
-
Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.
Jones D,
Kamel-Reid S, Bahler D, Dong H, Elenitoba-Johnson K, Press R, Quigley N, Rothberg P, Sabath D, Viswanatha D, Weck K, Zehnder J.
J Mol Diagn.
2009;
11
(1):
4-11
-
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing.
Boyd SD,
Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Fire AZ.
Sci Transl Med.
2009;
1
(12):
12ra23
-
Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remission.
Medeiros BC,
Gotlib J, Zehnder J.
Leuk Lymphoma.
2009;
50
(5):
851-3
-
Gene expression and pathway analysis of immune thrombocytopenic purpura.
Sood R,
Wong W, Gotlib J, Jeng M, Zehnder JL.
Br J Haematol.
2008;
140
(1):
99-103
-
Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers.
Dumur CI,
Lyons-Weiler M, Sciulli C, Garrett CT, Schrijver I, Holley TK, Rodriguez-Paris J, Pollack JR, Zehnder JL, Price M, Hagenkord JM, Rigl CT, Buturovic LJ, Anderson GG, Monzon FA.
J Mol Diagn.
2008;
10
(1):
67-77
-
Superficial venous thrombosis associated with congenital absence of the inferior vena cava and previous episode of deep venous thrombosis.
Evanchuk DM,
Von Gehr A, Zehnder JL.
Am J Hematol.
2008;
83
(3):
250-2
-
Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Zerboni L,
Reichelt M, Jones CD, Zehnder JL, Ito H, Arvin AM.
Proc Natl Acad Sci U S A.
2007;
104
(35):
14086-91
-
Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
Duhl AJ,
Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, Hamersley SL, Hyers TM, Katz V, Kuhlmann R, Nutescu EA, Thorp JA, Zehnder JL.
Am J Obstet Gynecol.
2007;
197
(5):
457.e1-21
-
Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial.
Gardner CD,
Zehnder JL, Rigby AJ, Nicholus JR, Farquhar JW.
Blood Coagul Fibrinolysis.
2007;
18
(8):
787-93
-
Identification of an intronic single nucleotide polymorphism leading to allele dropout during validation of a CDH1 sequencing assay: implications for designing polymerase chain reaction-based assays.
Mullins FM,
Dietz L, Lay M, Zehnder JL, Ford J, Chun N, Schrijver I.
Genet Med.
2007;
9
(11):
752-60
-
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
Rawstron AC,
Villamor N, Ritgen M, Böttcher S, Ghia P, Zehnder JL, Lozanski G, Colomer D, Moreno C, Geuna M, Evans PA, Natkunam Y, Coutre SE, Avery ED, Rassenti LZ, Kipps TJ, Caligaris-Cappio F, Kneba M, Byrd JC, Hallek MJ, Montserrat E, Hillmen P.
Leukemia.
2007;
21
(5):
956-64
-
Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories.
Price EA,
Hayward CP, Moffat KA, Moore JC, Warkentin TE, Zehnder JL.
Thromb Haemost.
2007;
98
(6):
1357-61
-
Molecular characterization and subcellular localization of Tyr478del: a pathogenic in-frame deletion in coagulation factor V.
Jones CD,
Yeung C, Negro F, Zehnder JL.
J Thromb Haemost.
2007;
5
(2):
431-3
-
Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults.
Carlson JJ,
Farquhar JW, DiNucci E, Ausserer L, Zehnder J, Miller D, Berra K, Hagerty L, Haskell WL.
J Am Diet Assoc.
2007;
107
(3):
422-32
-
Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q.
Caudill JS,
Sood R, Zehnder JL, Pruthi RK, Steensma DP.
J Thromb Haemost.
2007;
5
(3):
626-8
-
T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.
Thurber SE,
Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S.
J Am Acad Dermatol.
2007;
57
(5):
782-90
-
Testing for maternal cell contamination in prenatal samples: a comprehensive survey of current diagnostic practices in 35 molecular diagnostic laboratories.
Schrijver I,
Cherny SC, Zehnder JL.
J Mol Diagn.
2007;
9
(3):
394-400
-
Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis.
Lay M,
Mariappan R, Gotlib J, Dietz L, Sebastian S, Schrijver I, Zehnder JL.
J Mol Diagn.
2006;
8
(3):
330-4
-
First molecular characterization of a patient with combined factor V and factor VII deficiency.
Traynis I,
Jones CD, Gibb CB, Acharya SS, Zehnder JL.
Thromb Haemost.
2006;
95
(6):
1031-2
-
Gene expression patterns in human placenta.
Sood R,
Zehnder JL, Druzin ML, Brown PO.
Proc Natl Acad Sci U S A.
2006;
103
(14):
5478-83
-
Gene expression profile of idiopathic thrombocytopenic purpura (ITP).
Sood R,
Wong W, Jeng M, Zehnder JL.
Pediatr Blood Cancer.
2006;
47
(5 Suppl):
675-7
-
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network.
Kahl BS,
Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH.
Ann Oncol.
2006;
17
(9):
1418-23
-
Mast cells can promote the development of multiple features of chronic asthma in mice.
Yu M,
Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ.
J Clin Invest.
2006;
116
(6):
1633-41
-
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Manno CS,
Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Rasko J, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA.
Nat Med.
2006;
12
(3):
342-7
-
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.
Jamieson CH,
Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, Jones C, Zehnder JL, Lilleberg SL, Weissman IL.
Proc Natl Acad Sci U S A.
2006;
103
(16):
6224-9
-
A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma.
Le QT,
Jones CD, Yau TK, Shirazi HA, Wong PH, Thomas EN, Patterson BK, Lee AW, Zehnder JL.
Clin Cancer Res.
2005;
11
(16):
5700-7
-
Characterization of a novel prothrombin variant, Prothrombin C20209T, as a modifier of thrombotic risk among African-Americans.
Itakura H,
Telen MJ, Hoppe CC, White DA, Zehnder JL.
J Thromb Haemost.
2005;
3
(10):
2357-9
-
High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review.
Schrijver I,
Hong DW, Mandle L, Jones CD, DiMichele D, Monahan PE, Zehnder JL.
Thromb Haemost.
2005;
93
(3):
610-1
-
Identification of mislabeled specimen by molecular methods: case report and review.
Mariappan MR,
Zehnder J, Arber DA, Lay M, Fadare O, Schrijver I.
Int J Surg Pathol.
2005;
13
(3):
253-8
-
Varicella-zoster virus infection of human dorsal root ganglia in vivo.
Zerboni L,
Ku CC, Jones CD, Zehnder JL, Arvin AM.
Proc Natl Acad Sci U S A.
2005;
102
(18):
6490-5
-
Congenital and acquired thrombocytopenia.
Cines DB,
Bussel JB, McMillan RB, Zehnder JL.
Hematology Am Soc Hematol Educ Program.
2004:
390-406
-
CyclinD1/CyclinD3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma.
Jones CD,
Darnell KH, Warnke RA, Zehnder JL.
J Mol Diagn.
2004;
6
(2):
84-9
-
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.
Jamieson CH,
Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL.
N Engl J Med.
2004;
351
(7):
657-67
-
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.
Wrone EM,
Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP.
J Am Soc Nephrol.
2004;
15
(2):
420-6
-
Rapid combined genotyping assay for four achondroplasia and hypochondroplasia mutations by real-time PCR with multiple detection probes.
Schrijver I,
Lay MJ, Zehnder JL.
Genet Test.
2004;
8
(2):
185-9
-
Comprehensive validation of a real-time quantitative bcr-abl assay for clinical laboratory use.
Jones CD,
Yeung C, Zehnder JL.
Am J Clin Pathol.
2003;
120
(1):
42-8
-
Diagnostic single nucleotide polymorphism analysis of factor V Leiden and prothrombin 20210G > A. A comparison of the Nanogen Eelectronic Microarray with restriction enzyme digestion and the Roche LightCycler.
Schrijver I,
Lay MJ, Zehnder JL.
Am J Clin Pathol.
2003;
119
(4):
490-6
-
Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.
Gotlib J,
Kohler S, Reicherter P, Oro AE, Zehnder JL.
Arch Dermatol.
2003;
139
(8):
1081-3
-
Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi's histiocytic necrotizing lymphadenitis.
George TI,
Jones CD, Zehnder JL, Warnke RA, Dorfman RF.
Hum Pathol.
2003;
34
(2):
130-5
-
Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality.
Zackheim HS,
Jones C, Leboit PE, Kashani-Sabet M, McCalmont TH, Zehnder J.
J Am Acad Dermatol.
2003;
49
(4):
620-3
-
Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation.
Schrijver I,
Lenzi TJ, Jones CD, Lay MJ, Druzin ML, Zehnder JL.
J Mol Diagn.
2003;
5
(4):
250-3
-
Homozygous factor V splice site mutation associated with severe factor V deficiency.
Schrijver I,
Koerper MA, Jones CD, Zehnder JL.
Blood.
2002;
99
(8):
3063-5
-
Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding.
Schrijver I,
Houissa-Kastally R, Jones CD, Garcia KC, Zehnder JL.
Thromb Haemost.
2002;
87
(2):
294-9
-
Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine.
Zackheim HS,
Koo J, LeBoit PE, McCalmont TH, Bowman PH, Kashani-Sabet M, Jones C, Zehnder J.
J Am Acad Dermatol.
2002;
47
(1):
155-7
-
A polymorphism in the BCL-6 gene is associated with follicle center lymphoma.
Lossos IS,
Jones CD, Zehnder JL, Levy R.
Leuk Lymphoma.
2001 Nov-Dec;
42
(6):
1343-50
-
An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
Wrone EM,
Zehnder JL, Hornberger JM, McCann LM, Coplon NS, Fortmann SP.
Kidney Int.
2001;
60
(3):
1106-13
-
CD31 mismatching affects marrow transplantation outcome.
Grumet FC,
Hiraki DD, Brown BWM, Zehnder JL, Zacks ES, Draksharapu A, Parnes J, Negrin RS.
Biol Blood Marrow Transplant.
2001;
7
(9):
503-12
-
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS,
Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R.
Blood.
2001;
98
(4):
945-51
-
Immunological consequences of topical bovine thrombin.
Zehnder JL,
Leung LL.
Am J Pathol.
2001;
159
(6):
2371
-
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
Nakada MT,
Amin K, Christofidou-Solomidou M, O'Brien CD, Sun J, Gurubhagavatula I, Heavner GA, Taylor AH, Paddock C, Sun QH, Zehnder JL, Newman PJ, Albelda SM, DeLisser HM.
J Immunol.
2000;
164
(1):
452-62
-
Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases.
Natkunam Y,
Warnke RA, Zehnder JL, Jones CD, Milatovich-Cherry A, Cornbleet PJ.
Am J Surg Pathol.
2000;
24
(4):
525-34
-
PCR-heteroduplex analysis of T-cell receptor gamma gene rearrangement in paraffin-embedded skin biopsies.
Kohler S,
Jones CD, Warnke RA, Zehnder JL.
Am J Dermatopathol.
2000;
22
(4):
321-7
-
Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
Higgins JP,
van de Rijn M, Jones CD, Zehnder JL, Warnke RA.
Am J Clin Pathol.
2000;
114
(2):
236-47
-
Sensitive detection of clonal immunoglobulin rearrangements in frozen and paraffin embedded tissues by polymerase chain reaction heteroduplex analysis.
Ranheim EA,
Jones CD, Zehnder JL.
Diagn Mol Pathol.
2000;
9
(4):
177-83
-
Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases.
Natkunam Y,
Smoller BR, Zehnder JL, Dorfman RF, Warnke RA.
Am J Surg Pathol.
1999;
23
(5):
571-81
-
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation.
Natkunam Y,
Warnke RA, Zehnder JL, Cornbleet PJ.
Am J Clin Pathol.
1999;
111
(5):
663-71
-
Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford [erratum].
Zehnder JL,
Hiraki DD, Jones CD, Gross N, Grumet FC.
Thromb Haemost.
1999;
82
(5):
XII
-
Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford.
Zehnder JL,
Hiraki DD, Jones CD, Gross N, Grumet FC.
Thromb Haemost.
1999;
82
(3):
1097-9
-
Mast-cell heparin demystified.
Zehnder JL,
Galli SJ.
Nature.
1999;
400
(6746):
714-5
-
Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD).
Olsson K,
Gerard CJ, Zehnder J, Jones C, Ramanathan R, Reading C, Hanania EG.
Leukemia.
1999;
13
(11):
1833-42
-
The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used.
Hursting MJ,
Zehnder JL, Joffrion JL, Becker JC, Knappenberger GD, Schwarz RP.
Clin Chem.
1999;
45
(3):
409-12
-
Use of the polymerase chain reaction in the evaluation of cutaneous T-cell infiltrates.
Kohler S,
Zehnder JL.
Dermatol Clin.
1999;
17
(3):
657-66, x
-
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study.
Johnson PW,
Swinbank K, MacLennan S, Colomer D, Debuire B, Diss T, Gabert J, Gupta RK, Haynes A, Kneba M, Lee MS, Macintyre E, Mensink E, Moos M, Morgan GJ, Neri A, Johnson A, Reato G, Salles G, van't Veer MB, Zehnder JL, Zucca E, Selby PJ, Cotter FE.
Ann Oncol.
1999;
10
(11):
1349-54
-
Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty.
Woolson ST,
Zehnder JL, Maloney WJ.
J Arthroplasty.
1998;
13
(2):
207-10
-
Mesenteric artery thrombosis: a case report of combined protein S and protein C deficiency.
Atkins KA,
Zehnder JL.
Am J Hematol.
1998;
58
(3):
246-7
-
A microplate allele-specific oligonucleotide hybridization assay for detection of factor V Leiden.
Zehnder JL,
Benson RC, Cheng S.
Diagn Mol Pathol.
1997;
6
(6):
347-52
-
Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease.
Chen Y,
Schlegel PG, Tran N, Thompson D, Zehnder JL, Chao NJ.
Blood.
1997;
89
(4):
1452-9
-
Cross-linking hybridization assay for direct detection of factor V Leiden mutation.
Zehnder J,
Van Atta R, Jones C, Sussman H, Wood M.
Clin Chem.
1997;
43
(9):
1703-8
-
Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
Look KA,
Sahud M, Flaherty S, Zehnder JL.
Am J Clin Pathol.
1997;
108
(1):
78-82
-
Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.
Behar E,
Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC.
N Engl J Med.
1996;
334
(5):
286-91
-
Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency.
Zehnder JL,
Jain M.
Blood Coagul Fibrinolysis.
1996;
7
(3):
361-2
-
Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
Zehnder JL,
Benson RC.
Am J Clin Pathol.
1996;
106
(1):
107-11
-
Histidine-rich glycoprotein: is there a role in hemostasis or immune function?
Zehnder JL,
Leung LL.
J Lab Clin Med.
1995;
125
(6):
682-3
-
Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide.
Zehnder JL,
Shatsky M, Leung LL, Butcher EC, McGregor JL, Levitt LJ.
Blood.
1995;
85
(5):
1282-8
-
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes.
Zehnder JL,
Hirai K, Shatsky M, McGregor JL, Levitt LJ, Leung LL.
J Biol Chem.
1992;
267
(8):
5243-9
-
Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
Zehnder JL,
Leung LL.
Blood.
1990;
76
(10):
2011-6
-
Torsades de pointes precipitated by a Chinese herbal remedy.
Bryer-Ash M,
Zehnder J, Angelchik P, Maisel A.
Am J Cardiol.
1987;
60
(14):
1186-7
-
Reinvestigation of the reaction of chymotrypsin with N-furylacryloyltryptophan derivatives at acidic pH.
Fink AL,
Feldman R, Zehnder J.
Biochem J.
1979;
181
(3):
733-6
Navigation for This Section: Department of Medicine
Find a Researcher
Help